Low EIF2B5 expression predicts poor prognosis in ovarian cancer.

Medicine (Baltimore) · 2020 · PMC7004721 · PMID 32000373

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Moreover, EIF2B5 expression showed a decreasing trend from stage I to stage IV ovarian cancer, suggesting that the function of EIF2B5 may change throughout different stages of ovarian cancer.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.